These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25261447)

  • 1. Towards a unified vision of copper involvement in Alzheimer's disease: a review connecting basic, experimental, and clinical research.
    Pal A; Siotto M; Prasad R; Squitti R
    J Alzheimers Dis; 2015; 44(2):343-54. PubMed ID: 25261447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper imbalance and oxidative stress in neurodegeneration.
    Rossi L; Arciello M; Capo C; Rotilio G
    Ital J Biochem; 2006; 55(3-4):212-21. PubMed ID: 17274527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
    Greenough MA; Camakaris J; Bush AI
    Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
    Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM
    J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper-dependent oxidative stress and neurodegeneration.
    Rotilio G; Carrì MT; Rossi L; Ciriolo MR
    IUBMB Life; 2000; 50(4-5):309-14. PubMed ID: 11327325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.
    Park JH; Lee DW; Park KS
    Asia Pac Psychiatry; 2014 Mar; 6(1):38-45. PubMed ID: 23857910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper and Alzheimer's disease.
    Donnelly PS; Xiao Z; Wedd AG
    Curr Opin Chem Biol; 2007 Apr; 11(2):128-33. PubMed ID: 17300982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is brain copper deficiency in Alzheimer's, Lewy body, and Creutzfeldt Jakob diseases the common key for a free radical mechanism and oxidative stress-induced damage?
    Deloncle R; Guillard O
    J Alzheimers Dis; 2015; 43(4):1149-56. PubMed ID: 25125459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease as copper deficiency.
    Klevay LM
    Med Hypotheses; 2008; 70(4):802-7. PubMed ID: 17928161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agents complexing copper as a therapeutic strategy for the treatment of Alzheimer's disease.
    Squitti R; Salustri C
    Curr Alzheimer Res; 2009 Dec; 6(6):476-87. PubMed ID: 19747159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiocopper for the imaging of copper metabolism.
    Hueting R
    J Labelled Comp Radiopharm; 2014 Apr; 57(4):231-8. PubMed ID: 24634197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper brain homeostasis: role of amyloid precursor protein and prion protein.
    Inestrosa NC; Cerpa W; Varela-Nallar L
    IUBMB Life; 2005 Sep; 57(9):645-50. PubMed ID: 16203684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metal theory of Alzheimer's disease.
    Bush AI
    J Alzheimers Dis; 2013; 33 Suppl 1():S277-81. PubMed ID: 22635102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,1'-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: a new potential copper chelator agent for neuroprotection in Alzheimer's disease. Its comparative effects with clioquinol on rat brain copper distribution.
    Moret V; Laras Y; Pietrancosta N; Garino C; Quéléver G; Rolland A; Mallet B; Norreel JC; Kraus JL
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3298-301. PubMed ID: 16581247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper in Alzheimer's disease: too much or too little?
    Quinn JF; Crane S; Harris C; Wadsworth TL
    Expert Rev Neurother; 2009 May; 9(5):631-7. PubMed ID: 19402774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and functions of copper in brain.
    Scheiber IF; Mercer JF; Dringen R
    Prog Neurobiol; 2014 May; 116():33-57. PubMed ID: 24440710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tachykinin peptide neurokinin B binds copper(I) and silver(I) and undergoes quasi-reversible electrochemistry: towards a new function for the peptide in the brain.
    Grosas AB; Kalimuthu P; Smith AC; Williams PA; Millar TJ; Bernhardt PV; Jones CE
    Neurochem Int; 2014 May; 70():1-9. PubMed ID: 24650723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-copper diet as a preventive strategy for Alzheimer's disease.
    Squitti R; Siotto M; Polimanti R
    Neurobiol Aging; 2014 Sep; 35 Suppl 2():S40-50. PubMed ID: 24913894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.